概述

  • 产品名称Anti-CLECL1抗体
    参阅全部 CLECL1 一抗
  • 描述
    兔多克隆抗体to CLECL1
  • 经测试应用适用于: WBmore details
  • 种属反应性
    与反应: Human
  • 免疫原

    Synthetic peptide corresponding to a region within the N terminal amino acids 2-51 (VSNFFHVIQV FEKSATLISK TEHIGFVIYS WRKSTTHLGS RRKFAISIYL) of Human CLECL1 (NP_742001).

  • 阳性对照
    • THP1 cell lysate.

性能

相关产品

应用

Our Abpromise guarantee covers the use of ab87297 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
WB Use a concentration of 1 µg/ml. Predicted molecular weight: 19 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.

靶标

  • 相关性CLECL1 is a type II transmembrane, C-type lectin-like protein expressed on dendritic cells (DCs) and B cells. It interacts with subsets of T cells as a costimulatory molecule that enhances interleukin-4 (IL4) production.
  • 细胞定位Cell membrane; Single-pass type II membrane protein.
  • 数据库链接
  • 别名
    • C-type lectin-like 1 antibody
    • C-type lectin-like domain family 1 antibody
    • DC-associated lectin-1 antibody
    • DCAL-1 antibody
    • DCAL1 antibody
    • Dendritic cell associated lectin 1 antibody
    • Dendritic cell-associated lectin 1 antibody
    • Dendritic cell-associated lectin-1 antibody
    • Type II transmembrane protein DCAL1 antibody
    see all

Anti-CLECL1 antibody 图像

  • Anti-CLECL1 antibody (ab87297) at 1 µg/ml (in 5% skim milk / PBS buffer) + THP1 cell lysate at 10 µg

    Secondary
    HRP conjugated anti-Rabbit IgG at 1/50000 dilution

    Predicted band size : 19 kDa
    Observed band size : 19 kDa

Anti-CLECL1 antibody (ab87297)参考文献

ab87297 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab87297.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"